Choose License Type
The rising incidence of chronic diseases, along with diabetes, is expected to be one of the market's drivers of maximum impact. This resulting rise in disease prevalence has prompted industries to develop large-scale, advanced analyzers to assist with diagnosis. As a result, the high demand for chemical analyzers has led to exponential growth in new entrants to the industry, resulting in high levels of competition.
In the fields of oncology, gynecology, & endocrinology, technical advances in clinical chemistry analyzers have led to early detection of diseases and specialized diagnosis and allowed larger-scale research. The advances include advanced modeling & estimation of parameters, better resolution, enhanced identification of patterns, computer-assisted interpretation, and artificial intelligence.
Automatic data collection, greater process control allowing real-time automation, effective parameter tracking, and automatic variable adjustment are the advantages of the above-mentioned innovations and automated analyzers. These tools also provide analysis of a wide range of samples and promote immediate results generation, representing their potential applications in the intensive care unit, outpatient clinics, and future emergency as well as surgical wards. These advantages are expected to drive the preference of physicians for these analyzers, thereby generating high potential growth opportunities during the forecast era.
The aim of the report is to estimate the size of the market for clinical chemistry analyzers and reagents and the future growth potential of the market for clinical chemistry analyzers and reagents across various segments, such as patient position and component. The base year considered for the analysis is 2019 and from forecast is provided from 2020-2028.
In terms of product, reagents accounted for the largest share in 2019. The significant share is projected to be the product of a wide variety of reagents on the market, catering to various clinician requirements. Enzymes, substrates, particular proteins, electrolytes, lipids, and others are primarily found in these reagents, which are imperative in analytical procedures for accurate results. In addition, reagents are thought to be highly cost-effective, have optimal sensitivity, linearity, and accuracy, thus ensuring minimized variation in efficiency. It is expected that the aforementioned advantages are highly responsible for motivating clinicians to use reagents for accurate diagnosis.
Key vendors in the market include A Mindray Medical International Limited, Thermo Fisher Scientific Inc., Danaher Corporation, Abbott Laboratories, Abbott Laboratories, F.Hoffmann-La Roche Ltd., and many more.
Key Segments of the Global Clinical Chemistry Analyzers and Reagents Market
Product Overview, 2018-2028 (USD Million)
Test Overview, 2018-2028 (USD Million)
End-use Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Important Companies in Global Clinical Chemistry Analyzers and Reagents Market
Reasons for the study
What does the report include?
Who should buy this report?
The rising incidence of chronic diseases, along with diabetes, is expected to be one of the market's drivers of maximum impact. This resulting rise in disease prevalence has prompted industries to develop large-scale, advanced analyzers to assist with diagnosis. As a result, the high demand for chemical analyzers has led to exponential growth in new entrants to the industry, resulting in high levels of competition.
In the fields of oncology, gynecology, & endocrinology, technical advances in clinical chemistry analyzers have led to early detection of diseases and specialized diagnosis and allowed larger-scale research. The advances include advanced modeling & estimation of parameters, better resolution, enhanced identification of patterns, computer-assisted interpretation, and artificial intelligence.
Automatic data collection, greater process control allowing real-time automation, effective parameter tracking, and automatic variable adjustment are the advantages of the above-mentioned innovations and automated analyzers. These tools also provide analysis of a wide range of samples and promote immediate results generation, representing their potential applications in the intensive care unit, outpatient clinics, and future emergency as well as surgical wards. These advantages are expected to drive the preference of physicians for these analyzers, thereby generating high potential growth opportunities during the forecast era.
The aim of the report is to estimate the size of the market for clinical chemistry analyzers and reagents and the future growth potential of the market for clinical chemistry analyzers and reagents across various segments, such as patient position and component. The base year considered for the analysis is 2019 and from forecast is provided from 2020-2028.
In terms of product, reagents accounted for the largest share in 2019. The significant share is projected to be the product of a wide variety of reagents on the market, catering to various clinician requirements. Enzymes, substrates, particular proteins, electrolytes, lipids, and others are primarily found in these reagents, which are imperative in analytical procedures for accurate results. In addition, reagents are thought to be highly cost-effective, have optimal sensitivity, linearity, and accuracy, thus ensuring minimized variation in efficiency. It is expected that the aforementioned advantages are highly responsible for motivating clinicians to use reagents for accurate diagnosis.
Key vendors in the market include A Mindray Medical International Limited, Thermo Fisher Scientific Inc., Danaher Corporation, Abbott Laboratories, Abbott Laboratories, F.Hoffmann-La Roche Ltd., and many more.
Key Segments of the Global Clinical Chemistry Analyzers and Reagents Market
Product Overview, 2018-2028 (USD Million)
Test Overview, 2018-2028 (USD Million)
End-use Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Important Companies in Global Clinical Chemistry Analyzers and Reagents Market
Reasons for the study
What does the report include?
Who should buy this report?
1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Market Size Estimation
2.4. Market Forecast
2.5. Data Triangulation
2.6. Assumptions and Limitations
3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/Challenges
3.3.3. Opportunities
3.4. Porter’s Five Forces Analysis
3.5. COVID-19 impact analysis
4. Global Clinical chemistry analyzers and reagents Market by Product, 2018-2028 (USD Million)
4.1. Analyzers
4.2. Reagents
4.3. Others
5. Global Clinical chemistry analyzers and reagents Market by Test, 2018-2028 (USD Million)
5.1. Basic Metabolic Panel (BMP)
5.2. Electrolyte Panel
5.3. Liver Panel
5.4. Lipid Profile
5.5. Renal Profile
5.6. Thyroid Function Panel
5.7. Specialty Chemical Tests
6. Global Clinical chemistry analyzers and reagents Market by End-use, 2018-2028 (USD Million)
6.1. Hospitals
6.2. Academic Research Centers
6.3. Diagnostic Laboratories
6.4. Others
7. Global Clinical chemistry analyzers and reagents Market by Region, 2018-2028 (USD Million)
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Rest of Asia Pacific
7.4. Latin America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of Latin America
7.5. Middle East & Africa
8. Competitive Landscape
8.1. Company Positioning
8.2. Strategic Initiatives
8.2.1. Mergers & Acquisitions
8.2.2. New Product Launch
8.2.3. Investments
8.2.4. Expansion
8.2.5. Others
9. Company Profiles
(Overview, Products and Services Portfolio, Recent Initiatives, Company Financials)
9.1. Mindray Medical International Limited
9.2. Thermo Fisher Scientific Inc
9.3. Danaher Corporation
9.4. Abbott Laboratories
9.5. Johnson & Johnson
9.6. Siemens AG
9.7. F.Hoffmann-La Roche Ltd.
9.8. Elitech Group
9.9. Horiba, Ltd.
9.10. Randox Laboratories
10. Appendix
10.1. Primary Research Approach
10.1.1. Primary Interview Participants
10.1.2. Questionnaire
10.2. Related Reports
10.2.1. Published
10.2.2. Upcoming